134 related articles for article (PubMed ID: 9706062)
1. Effect of pancreatico-biliary secretions and GI transit time on the absorption and pharmacokinetic profile of ranitidine in humans.
Reynolds KS; Song MH; Heizer WD; Burns CB; Sica DA; Brouwer KL
Pharm Res; 1998 Aug; 15(8):1281-5. PubMed ID: 9706062
[TBL] [Abstract][Full Text] [Related]
2. Gastrointestinal transit and distribution of ranitidine in the rat.
Suttle AB; Brouwer KL
Pharm Res; 1995 Sep; 12(9):1316-22. PubMed ID: 8570528
[TBL] [Abstract][Full Text] [Related]
3. Comparative bioavailability of two tablet formulations of ranitidine hydrochloride in healthy volunteers.
Bawazir SA; Gouda MW; El-Sayed YM; Al-Khamis KI; Al-Yamani MJ; Niazy EM; Al-Rashood KA
Int J Clin Pharmacol Ther; 1998 May; 36(5):270-4. PubMed ID: 9629991
[TBL] [Abstract][Full Text] [Related]
4. Solid-phase extraction and determination of ranitidine in human plasma by a high-performance liquid chromatographic method utilizing midbore chromatography.
Farthing D; Brouwer KL; Fakhry I; Sica D
J Chromatogr B Biomed Sci Appl; 1997 Jan; 688(2):350-3. PubMed ID: 9061475
[TBL] [Abstract][Full Text] [Related]
5. Comparison of two compartmental models for describing ranitidine's plasmatic profiles.
Schaiquevich P; Niselman A; Rubio M
Pharmacol Res; 2002 May; 45(5):399-405. PubMed ID: 12123628
[TBL] [Abstract][Full Text] [Related]
6. Effect of gastric pH on erlotinib pharmacokinetics in healthy individuals: omeprazole and ranitidine.
Kletzl H; Giraudon M; Ducray PS; Abt M; Hamilton M; Lum BL
Anticancer Drugs; 2015 Jun; 26(5):565-72. PubMed ID: 25643050
[TBL] [Abstract][Full Text] [Related]
7. Regional gastrointestinal absorption of ranitidine in the rat.
Suttle AB; Brouwer KL
Pharm Res; 1995 Sep; 12(9):1311-5. PubMed ID: 8570527
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the influence of antacids and H2 antagonists on the absorption of moxifloxacin after oral administration of a 400mg dose to healthy volunteers.
Stass H; Böttcher MF; Ochmann K
Clin Pharmacokinet; 2001; 40 Suppl 1():39-48. PubMed ID: 11352441
[TBL] [Abstract][Full Text] [Related]
9. Inter- and intrasubject variations of ranitidine pharmacokinetics after oral administration to normal male subjects.
Shim CK; Hong JS
J Pharm Sci; 1989 Dec; 78(12):990-4. PubMed ID: 2614701
[TBL] [Abstract][Full Text] [Related]
10. Effect of prokinetic agents, cisapride and metoclopramide, on the bioavailability in humans and intestinal permeability in rats of ranitidine, and intestinal charcoal transit in rats.
Lee HT; Lee YJ; Chung SJ; Shim CK
Res Commun Mol Pathol Pharmacol; 2000; 108(5-6):311-23. PubMed ID: 11958284
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and bioequivalence study of ranitidine film tablets in healthy male subjects.
Gschwend MH; Guserle R; Erenmemişoglu A; Martin W; Tamur U; Kanzik I; Hincal AA
Arzneimittelforschung; 2007; 57(6):315-9. PubMed ID: 17688076
[TBL] [Abstract][Full Text] [Related]
12. A lack of pharmacokinetic interaction between ranitidine and piroxicam.
Dixon JS; Lacey LF; Pickup ME; Langley SJ; Page MC
Eur J Clin Pharmacol; 1990; 39(6):583-6. PubMed ID: 1982764
[TBL] [Abstract][Full Text] [Related]
13. Effect of acute hyperglycemia on basal, secretin and secretin + cholecystokinin stimulated exocrine pancreatic secretion in humans.
Lam WF; Masclee AA; Souverijn JH; Lamers CB
Life Sci; 1999; 64(8):617-26. PubMed ID: 10069525
[TBL] [Abstract][Full Text] [Related]
14. Effect of sodium acid pyrophosphate on ranitidine bioavailability and gastrointestinal transit time.
Koch KM; Parr AF; Tomlinson JJ; Sandefer EP; Digenis GA; Donn KH; Powell JR
Pharm Res; 1993 Jul; 10(7):1027-30. PubMed ID: 8397394
[TBL] [Abstract][Full Text] [Related]
15. Influence of polyethylene glycol 400 on the gastrointestinal absorption of ranitidine.
Basit AW; Podczeck F; Newton JM; Waddington WA; Ell PJ; Lacey LF
Pharm Res; 2002 Sep; 19(9):1368-74. PubMed ID: 12403075
[TBL] [Abstract][Full Text] [Related]
16. A modified two-portion absorption model to describe double-peak absorption profiles of ranitidine.
Yin OQ; Tomlinson B; Chow AH; Chow MS
Clin Pharmacokinet; 2003; 42(2):179-92. PubMed ID: 12537516
[TBL] [Abstract][Full Text] [Related]
17. The use of formulation technology to assess regional gastrointestinal drug absorption in humans.
Basit AW; Podczeck F; Newton JM; Waddington WA; Ell PJ; Lacey LF
Eur J Pharm Sci; 2004 Feb; 21(2-3):179-89. PubMed ID: 14757489
[TBL] [Abstract][Full Text] [Related]
18. Bile flow but not enterohepatic recirculation influences the pharmacokinetics of ranitidine in the rat.
Suttle AB; Brouwer KL
Drug Metab Dispos; 1994; 22(2):224-32. PubMed ID: 8013278
[TBL] [Abstract][Full Text] [Related]
19. Effect of Da-Cheng-Qi decoction on the pharmacokinetics of ranitidine in rats.
Tang WF; Wan MH; Huang QR; Zhu ZY; Zhao JL; Wu YZ; Huang X
Biomed Chromatogr; 2008 Aug; 22(8):851-6. PubMed ID: 18384065
[TBL] [Abstract][Full Text] [Related]
20. Effects of gender and phase of the menstrual cycle on the kinetics of ranitidine in healthy volunteers.
Flores Pérez J; Juárez Olguín H; Flores Pérez C; Pérez Guillé G; Guillé Pérez A; Camacho Vieyra A; Toledo López A; Carrasco Portugal M; Lares Asseff I
Chronobiol Int; 2003 May; 20(3):485-94. PubMed ID: 12868543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
